Skip to main content
logo
Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
28.55
-0.51 (-1.75%)
At close: Nov 5, 2026, 4:00 PM EST
29.56
+1.01 (3.54%)
After-hours: Nov 5, 2026, 7:30 PM EST

Viridian Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-453.58-342.6-269.95-237.73-129.87-79.41
Depreciation & Amortization
0.70.460.540.520.260.12
Loss (Gain) From Sale of Assets
-----0.08
Loss (Gain) From Sale of Investments
-6.62-6.76-15.66-11.49-0.210.96
Stock-Based Compensation
59.644.342.1567.1719.7714.47
Other Operating Activities
14.045.1716.790.267.49
Change in Accounts Receivable
39.94---0.35-0.45
Change in Accounts Payable
-0.776.56-0.07-12.0411.521.66
Change in Unearned Revenue
-----0.290.64
Change in Other Net Operating Assets
5.2716.479.672.624.38-0.12
Operating Cash Flow
-341.51-276.39-232.32-184.17-93.84-54.58
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.94-0.5-0.51-0.9-0.8-0.34
Sale of Property, Plant & Equipment
-----0.08
Investment in Securities
-457.04-37.07-228.14-93.35-114.33-74.03
Investing Cash Flow
-468.98-37.56-228.65-94.25-115.13-74.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-28.88-155-
Total Debt Issued
278.8828.88-155-
Net Debt Issued (Repaid)
224.1828.88-155-
Issuance of Common Stock
501.32366.99459.68146.79295.75116.59
Other Financing Activities
89.530.88-26.94-12.32-22.51-8.28
Financing Cash Flow
815426.74457.74225.67322.24125.28

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
4.51112.79-3.23-52.75113.28-3.6

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-343.44-276.89-232.83-185.07-94.64-54.92
Free Cash Flow Growth
------
Free Cash Flow Margin
-1305.42%-390.81%-77096.03%-58938.85%-5340.58%-1853.49%
Free Cash Flow Per Share
-3.29-3.27-3.43-4.13-2.95-4.61
Levered Free Cash Flow
-217.39-162.07-136.29-102.5-48.83-33.91
Unlevered Free Cash Flow
-202.19-158.98-134.92-101.66-48.52-33.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.022.151.820.890.29-
Change in Working Capital
44.3623.039.6-9.4315.961.72
SEC Filings: 10-K · 10-Q